Gold and silver prices increased on Tuesday after weaker US labor market and consumer confidence data reduced expectations for aggressive interest rate hikes. Spot gold rose 1.42% to about $4,172 an ounce, while silver gained 1.23% to around $61.27. Despite long-term Treasury yields remaining high, softer economic data and comments from the New York Fed president lowered the odds of a rate hike in October, supporting precious metals. Upcoming US inflation and employment reports will be key to determining if this rebound continues or if higher yields pressure metals again.
Gold and silver prices rebounded as softer US economic data cooled expectations for aggressive Fed rate hikes. For readers following US equities, here is Pluang's market snapshot as of Sep 30, 2026 03:02 WIB: out of 150 priced US stocks, 58 rose and 92 fell. Notable movers include Boeing Co (BA) at USD 185.41 with a 1-day change of -6.39% and Pluang order activity of 38% Sell / 62% Buy, BlackBerry Limited (BB) at USD 8.70 up 5.91% with 88% Sell / 12% Buy, and Affirm Holdings Inc (AFRM) at USD 67.55 down 5.55% with 0% Sell / 100% Buy.
Micron Technology is set to report record quarterly revenue of up to $51.33 billion, fueled by strong demand for high-bandwidth memory in the AI market. Earnings per share are expected to jump significantly to around $31.72, compared to $3.03 last ye...
Sangoma Technologies reported a smaller-than-expected loss with an EPS of -$0.08, beating analyst estimates of -$2.19, though its revenue of $48.55 million slightly missed expectations. Despite ongoing profitability challenges reflected in a negative...
Iovance Biotherapeutics has increased its full-year 2026 revenue guidance to $410-$420 million, reflecting nearly 60% growth driven by strong U.S. demand for its cancer therapy Amtagvi, which generated $91 million in Q2 sales. Analyst Joseph Pantgini...
uniQure's stock fell sharply by 37% following a four-year update on its AMT-130 gene therapy for Huntington's disease, which showed reduced effectiveness from 80% at three years to 44% at four years, failing to reach statistical significance. Despite...
Altrova Health Inc. has settled C$215,000 of outstanding debt by issuing 3,583,333 common shares at a price of C$0.06 per share to three creditors. This debt settlement did not bring in cash but helped reduce the company's liabilities and preserve ca...
